![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mulder Douwe Haelst Paul Wobbes Martgriet Gans Rijk Zijlstra Felix May Johan Smit Andries Tervaert Jan Doormaal Jasper
Publisher: Springer Publishing Company
ISSN: 0920-3206
Source: Cardiovascular Drugs and Therapy, Vol.21, Iss.2, 2007-04, pp. : 91-97
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Previous Menu Next
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-lowering therapy in diabetes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
National guidelines for lipid-lowering therapy unsatisfactory
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Colesevelam valuable adjunct in lipid-lowering therapy
Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Consider lipid-lowering therapy for patients with diabetes and hyperlipidaemia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-lowering therapy beneficial in the perioperative period
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :